搜尋結果
Search company information, interaction, images & medical diagnosis. The most comprehensive database of medicines available in China, Hong Kong, Taiwan, Malaysia, Singapore, Philippines, Vietnam, Thailand, Indonesia and India Register for a MIMS account ...
Packing/Price. 1000's ($1,500.00/pack) MIMS Class. Calcium Antagonists, Anti-Anginal Drugs. ATC Classification. C08DB01 - diltiazem : Belongs to the class of benzothiazepine derivative selective calcium-channel blockers with direct cardiac effects. Used in the treatment of cardiovascular diseases.
MIMS.com is the leading online source of drug information, interactions, images, dosage and side effects for healthcare professionals in Malaysia and beyond. Whether you are looking for the latest medical news, updates on clinical guidelines, or comprehensive drug databases, MIMS.com has it all. Join millions of users who trust MIMS.com as their essential medical reference.
Description. Tablet: AMK 375: Each tablet contains 250 mg of amoxicillin and 125 mg clavulanic acid. AMK 625: Each tablet contains 500 mg of amoxicillin and 125 mg clavulanic acid. AMK 1000: Each tablet contains 875 mg of amoxicillin and 125 mg clavulanic acid. The amoxicillin is present as amoxicillin trihydrate and the clavulanic acid is ...
Dosage/Direction for Use. Oral Use: Dissolve the granules in about ½ glass of water, avoiding the addition of drugs to the solution and taking it before or after meals. Adults: Acute Treatment: 1 sachet of 200 mg or 2 sachets of 100 mg 3 times daily for 5-10 days. Chronic Treatment: 1 sachet of 200 mg 2-3 times or 1 effervescent tablet daily ...
Search drug information, interaction, images & medical diagnosis. The most comprehensive database of medicines available in China, Hong Kong, Taiwan, Malaysia, Singapore, Philippines, Vietnam, Thailand, Indonesia and India Register for a MIMS account and ...
MIMS home. Drugs. Info. Duodart特尿通. dutasteride + tamsulosin. / Concise Prescribing Info. Contents. Dutasteride 0.5 mg, tamsulosin HCl 0.4 mg. Indications/Uses. Moderate to severe symptoms of benign prostatic hyperplasia (BPH). Reduction in the risk of acute urinary retention (AUR) & surgery in patients w/ moderate to severe BPH symptoms.
